Skip to main content

Advertisement

Log in

Receipt of recommended surveillance among colorectal cancer survivors: a systematic review

  • Review
  • Published:
Journal of Cancer Survivorship Aims and scope Submit manuscript

Abstract

Purpose

Regular surveillance decreases the risk of recurrent cancer in colorectal cancer (CRC) survivors. However, studies suggest that receipt of follow-up tests is not consistent with guidelines. This systematic review aimed to: (1) examine receipt of recommended post-treatment surveillance tests and procedures among CRC survivors, including adherence to established guidelines, and (2) identify correlates of CRC surveillance.

Methods

Systematic searches of Medline, PubMed, PsycINFO, CINAHL Plus, and Scopus databases were conducted using terms adapted for each database’s keywords and subject headings. Studies were screened for inclusion using a three-step process: (1) lead author reviewed abstracts of all eligible studies; (2) coauthors reviewed random 5 % samples of abstracts; and (3) two sets of coauthors reviewed all “maybe” abstracts. Discrepancies were adjudicated through discussion.

Results

Thirty-four studies are included in the review. Overall adherence ranged from 12 to 87 %. Within the initial 12 to 18 months post-treatment, adherence to recommended office visits was 93 %. Adherence ranged from 78 to 98 % for physical exams, 18–61 % for colonoscopy, and 17–71 % for carcinoembryonic antigen (CEA) testing. By 2 to 3 years post-treatment, cumulative adherence ranged from 70 to 88 % for office visits, 89–93 % for physical exams, 49–94 % for colonoscopy, and 7–79 % for CEA testing. Between 18 and 28 % of CRC survivors received greater than recommended overall surveillance; overuse of physical exams (42 %), colonoscopy (24–76 %), and metastatic disease testing (1–29 %) was also prevalent. Studies of correlates of CRC surveillance focused on sociodemographic and disease/treatment characteristics, and patterns of association were inconsistent across studies.

Conclusions

Deviation from surveillance recommendations includes both under- and overuse. Examination of modifiable determinants is needed to inform interventions targeting appropriate and timely receipt of recommended surveillance.

Implications for Cancer Survivors

Among CRC survivors, it remains unclear what modifiable psychosocial factors are associated with the observed under- and overuse of surveillance. Understanding and intervening with these psychosocial factors is critical to improving adherence to guideline-recommended surveillance and thereby reducing mortality among this group of survivors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. American Cancer Society. Cancer facts & figures 2012. Atlanta: American Cancer Society; 2012.

    Google Scholar 

  2. Hu C-Y, Delclos GL, Chan W, et al. Post-treatment surveillance in a large cohort of patients with colon cancer. Am J Manag Care. 2011;17:329–36.

    PubMed  Google Scholar 

  3. Hammond K, Margolin DA. The role of postoperative surveillance in colorectal cancer. Clin Colon Rectal Surg. 2007;20:249–54.

    Article  PubMed  Google Scholar 

  4. Obrand DI, Gordon PH. Incidence and patterns of recurrence following curative resection for colorectal carcinoma. Dis Colon Rectum. 1997;40:15–24.

    Article  CAS  PubMed  Google Scholar 

  5. Tjandra JJ, Chan MKY. Follow-up after curative resection of colorectal cancer: a meta-analysis. Dis Colon Rectum. 2007;50:1783–99.

    Article  PubMed  Google Scholar 

  6. Renehan AG, Egger M, Saunders MP, et al. Impact on survival of intensive follow-up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials. BMJ. 2002;324:1–8.

    Article  Google Scholar 

  7. Figueredo A, Rumble RB, Maroun J, et al. Follow-up of patients with curatively resected colorectal cancer: a practice guideline. BMC Cancer. 2003;3:26.

    Article  PubMed  Google Scholar 

  8. Kunitake H, Zheng P, Land SR, et al. Routine preventive care and cancer surveillance in long-term survivors of colorectal cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol LTS-01. J Clin Oncol. 2010;28:5274–9.

    Article  PubMed  Google Scholar 

  9. Anthony T, Simmang C, Hyman N, et al. Practice parameters for the surveillance and follow-up of patients with colon and rectal cancer. Dis Colon Rectum. 2004;47:807–17.

    Article  PubMed  Google Scholar 

  10. American Cancer Society. Colorectal cancer detailed guide; 6-17-2011. Available at: http://www.cancer.org/Cancer/ColonandRectumCancer/DetailedGuide/index. Accessed 17 June 2011.

  11. Rex DK, Kahi CJ, Levin B, et al. Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2006;130:1865–71.

    Article  PubMed  Google Scholar 

  12. Desch CE, Benson AB, Somerfield MR, et al. Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol. 2005;23:8512–9.

    Article  PubMed  Google Scholar 

  13. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: colon cancer, version 1. 2011; 8-30-2011.

  14. Jeffery M, Hickey BE, Hider PN. Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst Rev. 2007; CD002200.

  15. Boehmer U, Harris J, Bowen DJ, et al. Surveillance after colorectal cancer diagnosis in a safety net hospital. J Health Care Poor Underserved. 2010;21:1138–51.

    PubMed  Google Scholar 

  16. Borie F, Daures J-P, Millat B. Cost and effectiveness of follow-up examinations in patients with colorectal cancer resected for cure in a French population-based study. J Gastrointest Surg. 2004;8:552–8.

    Article  PubMed  Google Scholar 

  17. Boulin M, Lejeune C, Le Teuff G, et al. Patterns of surveillance practices after curative surgery for colorectal cancer in a French population. Dis Colon Rectum. 2005;48:1890–9.

    Article  PubMed  Google Scholar 

  18. Brawarsky P, Neville BA, Fitzmaurice GM, et al. Surveillance after resection for colorectal cancer. Cancer. 2013;119:1235–42.

    Article  PubMed  Google Scholar 

  19. Cardella J, Coburn NG, Gagliardi A. Compliance, attitudes and barriers to post-operative colorectal cancer follow-up. J Eval Clin Pract. 2008;14:407–15.

    Article  PubMed  Google Scholar 

  20. Cheung WY, Pond GR, Rother M, et al. Adherence to surveillance guidelines after curative resection for stage II/III colorectal cancer. Clin Colorectal Canc. 2008;7:191–6.

    Article  Google Scholar 

  21. Cooper GS, Yuan Z, Chak A, et al. Geographic and patient variation among Medicare beneficiaries in the use of follow-up testing after surgery for nonmetastatic colorectal carcinoma. Cancer. 1999;85:2124–31.

    Article  CAS  PubMed  Google Scholar 

  22. Cooper GS, Yuan Z, Chak A, et al. Patterns of endoscopic follow-up after surgery for nonmetastatic colorectal cancer. Gastrointest Endosc. 2000;52:33–8.

    Article  CAS  PubMed  Google Scholar 

  23. Cooper GS, Payes JD. Temporal trends in colorectal procedure use after colorectal cancer resection. Gastrointest Endosc. 2006;64:933–40.

    Article  PubMed  Google Scholar 

  24. Cooper GS, Kou TD, Reynolds HL. Receipt of guideline-recommended follow-up in older colorectal cancer survivors. Cancer. 2008;113:2029–37.

    Article  PubMed  Google Scholar 

  25. Ellison GL, Warren JL, Knopf KB, et al. Racial differences in the receipt of bowel surveillance following potentially curative colorectal cancer surgery. Health Serv Res. 2003;38:1885–904.

    Article  PubMed  Google Scholar 

  26. Elston Lafata J, Johnson CC, Ben-Menaghem T, et al. Sociodemographic differences in the receipt of colorectal cancer surveillance care following treatment with curative intent. Med Care. 2001;39:361–72.

    Article  CAS  PubMed  Google Scholar 

  27. Elston Lafata J, Simpkins J, Schultz L, et al. Routine surveillance care after cancer treatment with curative intent. Med Care. 2005;43:592–9.

    Article  PubMed  Google Scholar 

  28. Foley KL, Song E-Y, Klepin H, et al. Screening colonoscopy among colorectal cancer survivors insured by Medicaid. Am J Clin Oncol. 2011;35:205–11.

    Article  Google Scholar 

  29. Fox JP, Jeffery DD, Williams TV, et al. Quality of cancer survivorship care in the military health system (TRICARE). Cancer J. 2013;19:1–9.

    Article  PubMed  Google Scholar 

  30. Haggstrom DA, Arora NK, Helft P, et al. Follow-up care delivery among colorectal cancer survivors most often seen by primary and subspecialty care physicians. J Gen Intern Med. 2009;24:472–9.

    Article  Google Scholar 

  31. Hilsden RJ, Bryant HE, Sutherland LR, et al. A retrospective study on the use of post-operative colonoscopy following potentially curative surgery for colorectal cancer in a Canadian province. BMC Cancer. 2004;4:14.

    Article  PubMed  Google Scholar 

  32. Jackson GL, Melton D, Abbot DH, et al. Quality of nonmetastatic colorectal cancer care in the Department of Veterans Affairs. J Clin Oncol. 2010;28:3176–81.

    Article  PubMed  Google Scholar 

  33. Knopf KB, Warren JL, Feuer EJ, et al. Bowel surveillance patterns after a diagnosis of colorectal cancer in Medicare beneficiaries. Gastrointest Endosc. 2001;54:563–71.

    Article  CAS  PubMed  Google Scholar 

  34. Parsons HM, Tuttle TM, Kuntz KM, et al. Quality of care along the cancer continuum: Does receiving adequate lymph node evaluation for colon cancer lead to comprehensive postsurgical care? J Am Coll Surg. 2012; doi:10.1016/j.jamcollsurg.2012.05.014

  35. Pollack LA, Adamache W, Ryerson AB, et al. Care of long-term cancer survivors: physicians seen by Medicare enrollees surviving longer than 5 years. Cancer. 2009;115:5284–95.

    Article  PubMed  Google Scholar 

  36. Ramsey SD, Howlader N, Etzioni R, et al. Surveillance endoscopy does not improve survival for patients with local and regional stage colorectal cancer. Cancer. 2007;109:2222–8.

    Article  PubMed  Google Scholar 

  37. Rolnick S, Alford SH, Kucera GP, et al. Racial and age differences in colon examination surveillance following a diagnosis of colorectal cancer. J Natl Cancer Inst Monogr. 2005;35:96–101.

    Article  PubMed  Google Scholar 

  38. Rulyak SJ, Madelson MT, Brentnall TA, et al. Clinical and sociodemographic factors associated with colon surveillance among patients with a history of colorectal cancer. Gastrointest Endosc. 2004;59:239–47.

    Article  PubMed  Google Scholar 

  39. Rulyak SJ, Lieberman DA, Wagner EH, et al. Outcome of follow-up colon examination among a population-based cohort of colorectal cancer patients. Clin Gastroenterol H. 2007;5:470–6.

    Article  Google Scholar 

  40. Salloum RG, Hornbrook MC, Fishman PA, et al. Adherence to surveillance care guidelines after breast and colorectal cancer treatment with curative intent. Cancer. 2012. doi:10.1002/cncr.27544.

    PubMed  Google Scholar 

  41. Salz T, Weinberger M, Ayanian JZ, et al. Variation in use of surveillance colonoscopy among colorectal cancer survivors in the United States. BMC Health Serv Res. 2010;10:256–63.

    Article  PubMed  Google Scholar 

  42. Singh A, Kuo Y-F, Goodwin JS. Many patients who undergo surgery for colorectal cancer receive surveillance colonoscopies earlier than recommended by guidelines. Clin Gastroenterol H. 2013;11:65–72.

    Article  Google Scholar 

  43. Sisler JJ, Seo B, Katz A, et al. Concordance with ASCO guidelines for surveillance after colorectal cancer treatment: a population-based analysis. J Oncol Pract. 2012;8:e69–79.

    Article  PubMed  Google Scholar 

  44. Spratlin JL, Hui D, Hanson J, et al. Community compliance with carcinoembryonic antigen: follow-up of patients with colorectal cancer. Clin Colorectal Canc. 2008;7:118–25.

    Article  Google Scholar 

  45. Earle CC, Neville BA. Under use of necessary care among cancer survivors. Cancer. 2004;101:1712–9.

    Article  PubMed  Google Scholar 

  46. Mahboubi A, Lejeune C, Coriat R, et al. Which patients with colorectal cancer are followed up by general practitioners? A population-based study. Eur J Cancer Prev. 2007;16:535–41.

    Article  PubMed  Google Scholar 

  47. Sabatino SA, Thompson TD, Smith JL, et al. Receipt of cancer treatment summaries and follow-up instructions among adult cancer survivors: results from a national survey. J Cancer Surviv. 2013;7:32–43.

    Article  PubMed  Google Scholar 

  48. Treanor C, Donnelly M. An international review of the patterns and determinants of health service utilization by adult cancer survivors. BMC Health Serv Res. 2012;12:316.

    Article  PubMed  Google Scholar 

  49. Salz T, Woo H, Starr TD, et al. Ethnic disparities in colonoscopy use among colorectal cancer survivors: a systematic review. J Cancer Surviv. 2012;6:372–8.

    Article  PubMed  Google Scholar 

  50. Vandenbroucke JP, von Elm E, Altman DG, et al. Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. PLos Med. 2007;4:e297.

    Article  PubMed  Google Scholar 

  51. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med. 2009;151:65–94.

    Article  Google Scholar 

  52. Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions. Chichester: Wiley; 2008.

    Book  Google Scholar 

  53. Klabunde CN, Cronin KA, Breen N, et al. Trends in colorectal cancer test use among vulnerable populations in the United States. Cancer Epidemiol Biomarkers Prev. 2011;20:1611–21.

    Article  PubMed  Google Scholar 

  54. Potosky AL, Han PKJ, Rowland J, et al. Differences between primary care physicians’ and oncologists’ knowledge, attitudes and practices regarding the care of cancer survivors. J Gen Intern Med. 2011;26:1403–10.

    Article  PubMed  Google Scholar 

  55. Vernon SW, McQueen A. Colorectal cancer screening. In: Holland JC et al., editors. Psycho-oncology. 2nd ed. New York: Oxford University Press; 2010. p. 71–83.

    Chapter  Google Scholar 

  56. Salz T, Brewer NT, Sandler RS, et al. Association of health beliefs and colonoscopy use among survivors of colorectal cancer. J Cancer Surviv. 2009;3:193–201.

    Article  PubMed  Google Scholar 

  57. Taplin SH, Price RA, Edwards HM, et al. Introduction: understanding and influencing multilevel factors across the cancer care continuum. J Natl Cancer Inst Monogr. 2012;2012:2–10.

    Article  PubMed  Google Scholar 

  58. National Cancer Institute. Understanding and influencing multilevel factors across the cancer care continuum. J Natl Cancer Inst Monogr. 2012;2012:1–134.

    Article  Google Scholar 

  59. The COMMIT Research Group. Community intervention trial for smoking cessation (COMMIT): II. Changes in adult cigarette smoking prevalence. Am J Public Health. 1995;85:193–200.

    Article  Google Scholar 

  60. Lytle LA, Stone EJ, Nichaman MZ, et al. Changes in nutrient intakes of elementary school children following a school-based intervention: results from the CATCH study. Prev Med. 1996;25:465–77.

    Article  CAS  PubMed  Google Scholar 

  61. Lorig KR, Holman HR. Self-management education: history, definition, outcomes, and mechanisms. Ann Behav Med. 2003;26:1–7.

    Article  PubMed  Google Scholar 

  62. Cimprich B, Janz NK, Northouse L, et al. Taking charge: a self-management program for women following breast cancer treatment. Psychooncology. 2005;14:704–17.

    Article  PubMed  Google Scholar 

  63. Damush TM, Perkins A. The implementation of an oncologist referred, exercise self-management program for older breast cancer survivors. Psychooncology. 2006;15:884–90.

    Article  PubMed  Google Scholar 

  64. Stanton AL. Psychosocial concerns and interventions for cancer survivors. J Clin Oncol. 2008;24:5132–7.

    Article  Google Scholar 

  65. Grunfeld E. Primary care physicians and oncologists are players on the same team. J Clin Oncol. 2008;26:2246–7.

    Article  PubMed  Google Scholar 

  66. Hudson MM, Landier W, Ganz PA. Impact of survivorship-based research on defining clinical care guidelines. Cancer Epidemiol Biomarkers Prev. 2011;20:2085–92.

    Article  PubMed  Google Scholar 

  67. Grunfeld E, Mant D, Yudkin P, et al. Routine follow up of breast cancer in primary care: randomised trial. BMJ. 1996;313:665–9.

    Article  CAS  PubMed  Google Scholar 

  68. Grunfeld E, Levine MN, Julian JA, et al. Randomized trial of long-term follow-up for early stage breast cancer: a comparison of family physician versus specialist care. J Clin Oncol. 2006;24:848–55.

    Article  PubMed  Google Scholar 

  69. Wattchow DA, Weller DP, Esterman A, et al. General practice vs surgical-based follow-up for patients with colon cancer: randomised controlled trial. Br J Cancer. 2006;94:1116–21.

    Article  CAS  PubMed  Google Scholar 

  70. Del Giudice M, Grunfeld E, Harvey BJ, et al. Primary care physicians’ views of routine follow-up care of cancer survivors. J Clin Oncol. 2009;27:3338–45.

    Article  PubMed  Google Scholar 

  71. Steckler A, McLeroy KR. The importance of external validity. Am J Public Health. 2008;98:9–10.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors would like to thank Helena Vonville, MLS for her assistance in developing the search strategy. This work was supported by the National Cancer Institute at the National Institutes of Health (K07CA140159 to M.Y.C. and R01CA112223 to S.W.V.) and the Susan G. Komen Foundation (KG111378 to S.M.B.). S.M.B. was also supported by the Cancer Education and Career Development Program at the School of Public Health, University of Texas Health Science Center at Houston, funded by the National Cancer Institute (R25T 2R25CA57712). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute, the National Institutes of Health, or the Susan G. Komen Foundation.

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Melissa Y. Carpentier.

Appendix

Appendix

Search strategy for Ovid Medline

  1. 1.

    exp Colorectal neoplasms/

  2. 2.

    (crc or ((colorectal or colon or rectal) adj3 (cancer* or neoplasm* or polyp*))).ti,ab.

  3. 3.

    1 or 2

  4. 4.

    Survivors/ or survivor*.ti,ab.

  5. 5.

    3 and 4

  6. 6.

    Mass screening/

  7. 7.

    screen*.ti,ab.

  8. 8.

    surveillance.ti,ab. or follow-up.ti,ab.

  9. 9.

    exp Colonoscopy/

  10. 10.

    exp Sigmoidoscopy/

  11. 11.

    exp Endoscopy/

  12. 12.

    Barium enema.ti,ab.

  13. 13.

    Occult blood/

  14. 14.

    or/6–13

  15. 15.

    5 and 14

  16. 16.

    Limit 15 to English language

Search strategy for PubMed

  1. 1.

    Colorectal neoplasms[mesh0]

  2. 2.

    (crc[tiab] OR colorectal[tiab] OR colon[tiab] OR rectal[tiab] AND (cancer*[tiab] OR neoplasm*[tiab] OR polyp*[tiab])

  3. 3.

    #1 OR #2

  4. 4.

    Survivors[mesh:noexp] OR survivor*[tiab]

  5. 5.

    #3 AND #4

  6. 6.

    Mass screening[mesh:noexp]

  7. 7.

    Screen*[tiab]

  8. 8.

    Surveillance[tiab] OR follow-up[tiab]

  9. 9.

    Colonoscopy[mesh]

  10. 10.

    Sigmoidoscopy[mesh]

  11. 11.

    Endoscopy[mesh]

  12. 12.

    Barium enema[tiab]

  13. 13.

    Occult blood[mesh:noexp]

  14. 14.

    #6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13

  15. 15.

    #5 AND #14

  16. 16.

    #5 AND #14 Filters: English

Search strategy for Ovid PsycINFO

  1. 1.

    Colorectal neoplasms/

  2. 2.

    ((crc or colorectal or colon or rectal) adj4 (cancer* or neoplasm* or polyp*)).ti,ab,id.

  3. 3.

    1 or 2

  4. 4.

    Survivors/ or survivor*.ti,ab,id.

  5. 5.

    3 and 4

  6. 6.

    Mass screening.md.

  7. 7.

    Screen*.ti,ab,id.

  8. 8.

    Surveillance.ti,ab,id. or follow-up.ti,ab,id.

  9. 9.

    Colonoscopy/

  10. 10.

    Sigmoidoscopy/

  11. 11.

    Endoscopy/

  12. 12.

    Barium enema.ti,ab,id.

  13. 13.

    Occult blood/

  14. 14.

    or/6–13

  15. 15.

    5 and 14

  16. 16.

    Limit 15 to English language

Search strategy for CINAHL

  1. 1.

    (MH “Colorectal Neoplasms”)

  2. 2.

    TI ( (crc or colorectal or colon or rectal) and (cancer* or neoplasm* or polyp*) ) or AB ( (crc or colorectal or colon or rectal) and (cancer* or neoplasm* or polyp*) )

  3. 3.

    S1 or S2

  4. 4.

    (MH “Survivors”)

  5. 5.

    TI survivor* or AB survivor*

  6. 6.

    S4 or S5

  7. 7.

    S3 and S6

  8. 8.

    Mass screening/

  9. 9.

    TI screen* or AB screen*

  10. 10.

    TI (surveillance or follow-up) or AB (surveillance or follow-up)

  11. 11.

    (MH “Colonoscopy”)

  12. 12.

    (MH “Sigmoidoscopy”)

  13. 13.

    (MH “Endoscopy”)

  14. 14.

    TI barium enema or AB barium enema

  15. 15.

    Occult blood/

  16. 16.

    S8 or S9 or S10 or S11 or S12 or S13 or S14 or S15

  17. 17.

    S7 and S16

  18. 18.

    S7 and S16 limiters—English language

Rights and permissions

Reprints and permissions

About this article

Cite this article

Carpentier, M.Y., Vernon, S.W., Bartholomew, L.K. et al. Receipt of recommended surveillance among colorectal cancer survivors: a systematic review. J Cancer Surviv 7, 464–483 (2013). https://doi.org/10.1007/s11764-013-0290-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11764-013-0290-x

Keywords

Navigation